We discuss with Krishna Sundar (University of Utah, Salt Lake City, UT, USA) the association between chronic cough and obstructive sleep apnea.
- Could you tell us a little about the association between chronic cough and obstructive sleep apnea (OSA)? (0:05)
- What were the aims and design of your recent study investigating CPAP therapy for patients with OSA and chronic cough? (1:00)
- What were the findings of this study and what will be the clinical impact of these findings? (1:54)
Disclosures: Krishna Sundar discloses non-financial (only equipment) support from Respironics Inc. He has also acted as a site PI for Resmed Inc, is the Co-founder of Hypnoscure LLC (no monies) through the University of Utah Technology Commercialization Office and has participated in an advisory board for Merck Inc.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the CHEST 2020 Annual Meeting (Virtual).
Share this Video
Related Videos In Chronic Cough
Alan Kaplan: The IPCRG Sentinel Network and Respiratory Q&A
We were delighted to meet with Prof. Alan Kaplan (University of Toronto, Toronto, ON, Canada) to discuss the international IPCRG Sentinel Network which represents each continent and includes over 100 primary care clinicians. The IPCRG is providing answers based on published peer reviewed evidence to COVID and respiratory questions from the Sentinel Network. Questions Could […]
James Wingfield Digby, ERS 2022: Hypotonic Saline in the Diagnosis of Refractory/Unexplained Chronic Cough
Chronic cough is a persistent cough lasting ≥8 weeks and is estimated to affect between 2-18% of the global population; however chronic cough is often unrecognized, underdiagnosed and there remain many unmet needs in its treatment. It was a pleasure to speak with Dr. James Wingfield Digby (University of Manchester, Manchester, UK) around his study […]
James Wingfield Digby, ERS 2022: Low-dose Opiates for Refractory/Unexplained Chronic Cough
Chronic cough is a persistent cough lasting ≥8 weeks and is estimated to affect between 2-18% of the global population. touchRESPIRATORY were delighted to speak with Dr. James Wingfield Digby (University of Manchester, Manchester, UK) around the aims and design of the real world study investigating low-dose opiates in the treatment of chronic cough and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!